Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3383)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
120
Price
$546.38
Total Value
$65.57K
Shares Held After
197,746
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
761
Price
$544.83
Total Value
$414.62K
Shares Held After
197,866
% of Holdings
0.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
1,539
Price
$544.02
Total Value
$837.25K
Shares Held After
198,627
% of Holdings
0.8%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
1,202
Price
$542.60
Total Value
$652.21K
Shares Held After
200,166
% of Holdings
0.6%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
368
Price
$541.64
Total Value
$199.32K
Shares Held After
201,368
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
687
Price
$540.59
Total Value
$371.38K
Shares Held After
201,736
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
160
Price
$537.62
Total Value
$86.02K
Shares Held After
202,423
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
218
Price
$535.94
Total Value
$116.84K
Shares Held After
202,583
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
106
Price
$534.06
Total Value
$56.61K
Shares Held After
202,801
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
60
Price
$533.09
Total Value
$31.99K
Shares Held After
202,907
% of Holdings
0.0%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
33,558
Price
$3.81
Total Value
$127.86K
Shares Held After
752,309
% of Holdings
4.3%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP&Chief Legal Officer
Shares
1,200
Price
$240.94
Total Value
$289.13K
Shares Held After
47,671
% of Holdings
2.5%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
300
Price
$207.17
Total Value
$62.15K
Shares Held After
43,890
% of Holdings
0.7%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
1,179
Price
$206.10
Total Value
$242.99K
Shares Held After
44,190
% of Holdings
2.6%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
2,420
Price
$205.05
Total Value
$496.22K
Shares Held After
45,369
% of Holdings
5.1%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
5,530
Price
$204.14
Total Value
$1.13M
Shares Held After
47,789
% of Holdings
10.4%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
6,019
Price
$203.28
Total Value
$1.22M
Shares Held After
53,319
% of Holdings
10.1%
TG THERAPEUTICS, INC. (TGTX)
Charney Laurence N — Director
Shares
5,000
Price
$54.96
Total Value
$274.80K
Shares Held After
168,640
% of Holdings
2.9%
LIGAND PHARMACEUTICALS INC (LGND)
Zimmermann Martine — Director
Shares
1,200
Price
$285.00
Total Value
$342.00K
Shares Held After
3,897
% of Holdings
23.5%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,631
Price
$66.80
Total Value
$108.94K
Shares Held After
538,507
% of Holdings
0.3%
Moderna, Inc. (MRNA)
Mock James M — Chief Financial Officer
Shares
15,000
Price
$134.49
Total Value
$2.02M
Shares Held After
59,375
% of Holdings
20.2%
Moderna, Inc. (MRNA)
Mock James M — Chief Financial Officer
Shares
19,836
Price
$134.49
Total Value
$2.67M
Shares Held After
74,375
% of Holdings
21.1%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
919
Price
$33.15
Total Value
$30.46K
Shares Held After
3,613,123
% of Holdings
0.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
29,545
Price
$32.16
Total Value
$950.04K
Shares Held After
3,614,042
% of Holdings
0.8%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
1,439
Price
$33.16
Total Value
$47.71K
Shares Held After
3,613,056
% of Holdings
0.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
29,025
Price
$32.13
Total Value
$932.55K
Shares Held After
3,614,495
% of Holdings
0.8%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
11
Price
$33.34
Total Value
$366.74
Shares Held After
190,838
% of Holdings
0.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
9,525
Price
$32.46
Total Value
$309.14K
Shares Held After
190,849
% of Holdings
4.8%
Amylyx Pharmaceuticals, Inc. (AMLX)
Bedrosian Camille L — Chief Medical Officer
Shares
2,081
Price
$33.09
Total Value
$68.86K
Shares Held After
278,064
% of Holdings
0.7%
Amylyx Pharmaceuticals, Inc. (AMLX)
Bedrosian Camille L — Chief Medical Officer
Shares
7,947
Price
$32.21
Total Value
$256.00K
Shares Held After
280,145
% of Holdings
2.8%
Amylyx Pharmaceuticals, Inc. (AMLX)
FRATES JAMES M — Chief Financial Officer
Shares
1,042
Price
$33.23
Total Value
$34.63K
Shares Held After
233,625
% of Holdings
0.4%
Amylyx Pharmaceuticals, Inc. (AMLX)
FRATES JAMES M — Chief Financial Officer
Shares
9,768
Price
$32.27
Total Value
$315.19K
Shares Held After
234,667
% of Holdings
4.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
30,000
Price
$38.30
Total Value
$1.15M
Shares Held After
56,450
% of Holdings
34.7%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
10,000
Price
$2.73
Total Value
$27.30K
Shares Held After
996,967
% of Holdings
1.0%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
3,000
Price
$2.75
Total Value
$8.25K
Shares Held After
665,000
% of Holdings
0.5%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
37,595
Price
$1.32
Total Value
$49.52K
Shares Held After
773,296
% of Holdings
4.9%
Dominari Holdings Inc. (DOMH)
Hayes Anthony — Director
Shares
50,000
Price
$2.02
Total Value
$101.06K
Shares Held After
4,550,873
% of Holdings
1.1%
Dominari Holdings Inc. (DOMH)
Wool Kyle Michael — Director
Shares
50,000
Price
$2.02
Total Value
$101.06K
Shares Held After
4,261,828
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,412
Price
$107.58
Total Value
$582.23K
Shares Held After
767,780
% of Holdings
0.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
14,588
Price
$107.01
Total Value
$1.56M
Shares Held After
773,192
% of Holdings
1.9%
Aardvark Therapeutics, Inc. (AARD)
Sun Nelson — Chief Financial&Operating Officer
Shares
14,754
Price
$5.00
Total Value
$73.78K
Shares Held After
97,475
% of Holdings
13.1%
Candel Therapeutics, Inc. (CADL)
Tak Paul Peter — Director
Shares
220,866
Price
$11.50
Total Value
$2.54M
Shares Held After
172,700
% of Holdings
56.1%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
10,000
Price
$67.34
Total Value
$673.40K
Shares Held After
1,316,594
% of Holdings
0.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
20,500
Price
$96.31
Total Value
$1.97M
Shares Held After
688,209
% of Holdings
2.9%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
10,185
Price
$17.62
Total Value
$179.46K
Shares Held After
39,900
% of Holdings
20.3%
Travere Therapeutics, Inc. (TVTX)
Meckler Jeffrey A — Director
Shares
3,100
Price
$68.09
Total Value
$211.07K
Shares Held After
91,500
% of Holdings
3.3%
Travere Therapeutics, Inc. (TVTX)
Meckler Jeffrey A — Director
Shares
14,000
Price
$67.46
Total Value
$944.49K
Shares Held After
94,600
% of Holdings
12.9%
Travere Therapeutics, Inc. (TVTX)
Meckler Jeffrey A — Director
Shares
1,200
Price
$66.15
Total Value
$79.38K
Shares Held After
108,600
% of Holdings
1.1%
Travere Therapeutics, Inc. (TVTX)
Meckler Jeffrey A — Director
Shares
1,700
Price
$65.39
Total Value
$111.17K
Shares Held After
109,800
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$508.80
Total Value
$142.47K
Shares Held After
324,443
% of Holdings
0.1%
Showing 101–150 of 3383 transactions (page 3 of 68)